SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories gets VAI classification for Madhya Pradesh facility

23 Oct 2023 Evaluate

Ipca Laboratories has received voluntary action indicated (VAI) classification from the United States Food and Drug Administration (USFDA) for its Ratlam, Madhya Pradesh manufacturing facility. USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023. This facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP).  

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1778.20 -2.70 (-0.15%)
06-Jul-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1915.55
Dr. Reddys Labs. 1368.75
Cipla 1471.25
Zydus Lifesciences 1148.90
Lupin 2490.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: